pharmaceutical investing Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
Quimbaya Gold Inc. Announces Participation in THE Mining Investment Event, Quebec City, June 3-5, 2025
